Document:

Amendment No. 4 To Stockholders Agreement

 Exhibit 4.1 
  

AMENDMENT NO. 4 TO STOCKHOLDERS AGREEMENT 
  
 This Amendment No. 4 to Stockholders Agreement (this “Amendment”), dated as of November 28, 2005, by Concentra Inc. a Delaware
corporation formerly known as Concentra Managed Care, Inc. (the “Company”), and a majority in interest of each of the Schedule I Purchasers and FFC Purchasers (each as hereinafter defined). Capitalized terms used in this Amendment which
are not otherwise defined herein shall have the respective meanings assigned to them in the Stockholders Agreement referred to below. 
  
 WITNESSETH: 
  
 WHEREAS, the Company is party to a certain Stockholders Agreement dated as of August 17, 1999 (as amended, the “Stockholders
Agreement”), together with the several persons named on Schedule I thereto under the heading “Schedule I Purchasers” (the “Schedule I Purchasers”), and the several persons named on Schedule II thereto under the heading
“FFC Purchasers” (the “FFC Purchasers” and, together with the Schedule I Purchasers, collectively, the “Purchasers”); and 
  
 WHEREAS, on November 1, 2001, the Company issued to certain of its existing stockholders an aggregate 2,266,546 shares of Company Common Stock
and warrants to acquire an aggregate 771,277 additional shares of Company Common Stock and, in connection therewith, the Stockholders Agreement was amended by Amendment No. 1 thereto dated as of November 1, 2001, to provide for certain
matters relating to such shares and such warrants; and 
  
 WHEREAS, on November 20, 2002, the Company issued to certain of its existing stockholders an aggregate 1,515,152 shares of Company Common Stock and, in connection therewith, the Stockholders Agreement was amended by Amendment
No. 2 thereto dated as of November 20, 2002, to provide for certain matters relating to such shares; and 
  
 WHEREAS, in connection with the Company’s December 1, 2002, acquisition of Em3 Corporation (“Em3”), the Company issued an
aggregate 1,826,956 shares of Company Common Stock to certain of its existing stockholders and to certain former stockholders of Em3 who were not already stockholders of the Company, and, in connection therewith, the Stockholders Agreement was
amended by Amendment No. 3 thereto dated December 1, 2002 to provide for certain matters relating to such shares; and 
  
 WHEREAS, in connection with the appointment of Norman C. Payson, M.D. to the Company’s Board of Directors the Company issued an aggregate of
1,096,583 shares of Company Common Stock to Norman C. Payson, M.D., and the Company wishes to offer Dr. Payson the opportunity to become a party to the Stockholders Agreement as set forth herein; and 
  
 WHEREAS, pursuant to Section XIII.(6) thereof, the Stockholders
Agreement can be amended as set forth in this Amendment by approval of the Company and affirmative vote of a majority in interest of each of the Schedule I Purchasers and FFC Purchasers. 
  
 NOW, THEREFORE, in consideration of the foregoing and the mutual agreements and covenants set forth herein and other
good and valuable consideration, the parties hereto agree as follows: 
  

 1 

 1. Amendment to Stockholders Agreement. Schedule I to the Stockholders Agreement is hereby
amended to include each of the persons set forth in Exhibit A hereto “Joining Person”), upon such Joining Person’s execution and delivery of a Joinder Agreement substantially in the form attached hereto as Exhibit B.

  
 2. Miscellaneous. 
  
 (a) This Amendment shall be governed by and construed in accordance with the
laws of the State of New York. 
  
 (b) This Amendment may be
executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
  
 (c) Headings and section reference numbers in this Amendment are for reference purposes only and shall not in any way affect the meaning or interpretation
of this Amendment. 
  
 (d) This Amendment is limited precisely as
written and shall not be deemed to be a modification, acceptance or waiver of any other term, condition or provision of the Stockholders Agreement. 
  
 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written. 
  

			
	CONCENTRA INC.
		
	 By:
	 	 /s/  Richard A. Parr II

	 	 	 Richard A. Parr II

	 	 	 Executive Vice President

  
 [Schedule I
Purchasers and FFC Purchasers Signature Page Follows] 
  

 2 

 Schedule I Purchasers: 
  

			
	WELSH, CARSON, ANDERSON & STOWE VIII, L.P.
		
	By:	 	 WCAS VIII Associates, L.L.C.
 General
Partner

					
			
	 	 	 By:
	 	 /s/ Paul B. Queally

	 	 	 	 	 Managing Member

  

			
	WELSH, CARSON, ANDERSON & STOWE VI, L.P.
		
	By:	 	 WCAS VI ASSOCIATES, L.L.C.
 General
Partner

					
			
	 	 	 By:
	 	 /s/ Jonathan M. Rather

	 	 	 	 	 Jonathan M. Rather

	 	 	 	 	 Attorney-in-Fact

  
 FFC Purchasers:

			
	FERRER FREEMAN & COMPANY, LLC
	 on behalf of FFC PARTNERS I, L.P.
 and as its
General Partner

		
	By:	 	/s/ Carlos A. Ferrer
	 	 	 Carlos A. Ferrer
 Manager

  

					
	 and
	 	 

  

			
	 on behalf of FFC EXECUTIVE PARTNERS I,
 L.P. and as its General Partner

		
	By:	 	/s/ Carlos A. Ferrer
	 	 	 Carlos A. Ferrer
 Manager

	 
	and
	 
	 on behalf of FFC PARTNERS II, L.P.
 and as
its General Partner

		
	By:	 	/s/ Carlos A. Ferrer
	 	 	 Carlos A. Ferrer
 Manager

  

 3 

 EXHIBIT A 
  
 Joining Party 
  
 Norman C. Payson, M.D. 

 EXHIBIT B 
  
 Form of Joinder Agreement 
  
 JOINDER AGREEMENT 
  
 This Joinder Agreement (the “Joinder”) to the Amendment No. 4 to Stockholders Agreement, dated as of August 17, 1999 (as amended, the
“Stockholders Agreement”), among Concentra Inc. (f/k/a Concentra Managed Care, Inc.), a Delaware corporation (“Concentra”), and the several persons named in Schedules I and II thereto, is executed and delivered by Norman C.
Payson, M.D. (the “Joining Party”) as of November 28, 2005. Each capitalized term used but not otherwise defined herein shall have the meaning set forth in the Stockholders Agreement. 
  
 1. Agreement to be Bound. The Joining Party hereby agrees to be bound
by all of the terms of the Stockholders Agreement (as the same may be hereafter amended, restated, or otherwise modified from time to time). The Joining Party shall hereafter be deemed to be a “Schedule I Purchaser” and a
“Purchaser” for all purposes under the Stockholders Agreement. 
  
 2. Concentra Representations and Warranties. Concentra’s representations and warranties contained in the Stockholders Agreement are true and correct in all material respects as of the date hereof.

  
 3. Joining Party Representations and Warranties. The
Joining Party’s representations and warranties set forth in Section XI of the Stockholders Agreement are true and correct in all material respects as of the date hereof. 
  
 4. Notices. For purposes of notices and other communications to be delivered to the Joining Party, the addresses and
facsimile numbers set forth below shall be deemed an amendment to Schedule I of the Stockholders Agreement with respect to the Joining Party. 
  
 5. Governing Law. This Joinder Agreement shall be governed by and construed in accordance with the laws of the State of New York. 
  

									
	AGREED AND ACCEPTED	 	 	 	 
	 	 	 	 	Signature of Joining Party
	CONCENTRA INC.	 	 	 	 
	 	 	 	 	 	 	 	 	 Norman C. Payson, M.D.
 NCP, Inc.
 8 Centre Street, Suite 3

	By:	 	 	 	 	 	 	 	Concord, New Hampshire 03301
	 	 	Richard A. Parr II	 	 	 	 	 	 
	 	 	Executive Vice PresidentAmendment No. 5 To Registration Rights Agreement

 Exhibit 4.2 
  

AMENDMENT NO. 5 TO REGISTRATION RIGHTS AGREEMENT 
  

This Amendment No. 5 to Registration Rights Agreement (this “Amendment”), dated as of November 28, 2005, by Concentra Inc., a
Delaware corporation formerly known as Concentra Managed Care, Inc. (the “Company”), and a majority in interest of each of the Schedule I Purchasers and FFC Purchasers (each as hereinafter defined). Capitalized terms used in this Amendment
which are not otherwise defined herein shall have the respective meanings assigned to them in the Registration Rights Agreement referred to below. 
  
 WITNESSETH: 
  
 WHEREAS, the Company is party to a certain Registration Rights Agreement dated as of August 17, 1999 (as amended, the “Registration
Rights Agreement”), together with the several persons named on Schedule I thereto under the heading “Schedule I Purchasers” (the “Schedule I Purchasers”), and the several persons named on Schedule II thereto under the
heading “FFC Purchasers” (the “FFC Purchasers” and, together with the Schedule I Purchasers, collectively, the “Purchasers”); and 
  

WHEREAS, on November 1, 2001, the Company issued to certain of its existing shareholders an aggregate 2,266,546 shares of Company Common
Stock and warrants to acquire an aggregate 771,277 additional shares of Company Common Stock and, in connection therewith, the Registration Rights Agreement was amended by Amendment No. 1 thereto dated as of November 1, 2001, to provide
for certain registration matters relating to such 2,266,546 shares of Company Common Stock and the 771,277 shares of Company Common Stock issuable upon exercise of such warrants; and 
  
 WHEREAS, in connection with the Company’s November 2001 acquisition of National Healthcare Resources, Inc. (the
“NHR Merger”), the Registration Rights Agreement was further amended by Amendment No. 2 thereto dated as of November 5, 2001, to permit the Company to grant certain registration rights with respect to shares of Company Common
Stock issued by the Company in the NHR Merger; and 
  
 WHEREAS,
on November 20, 2002, the Company issued to certain of its existing shareholders an aggregate 1,515,152 shares of Company Common Stock and, in connection therewith, the Registration Rights Agreement was amended by Amendment No. 3
thereto dated as of November 20, 2002, to provide for certain registration matters relating to such 1,515,152 shares of Company Common Stock; and 
  
 WHEREAS, in connection with the Company’s December 1, 2002, acquisition of Em3 Corporation (“Em3”), the Company issued an
aggregate 1,826,956 shares of Company Common Stock to certain of its existing shareholders and to certain former shareholders of Em3 who were not already shareholders of the Company, and the Company wishes to afford to such new shareholders the
opportunity to become parties to the Registration Rights Agreement as set forth herein; and 
  
 WHEREAS, in connection with the appointment of Norman C. Payson, M.D. to the Company’s Board of Directors the Company issued an aggregate of 1,096,583 shares of Company 

  

 1 

 
Common Stock to Norman C. Payson, M.D., and the Company wishes to offer Dr. Payson the opportunity to become a party to the Registration Rights
Agreement as set forth herein; and 
  
 WHEREAS, pursuant to
Section 13(d) thereof, the Registration Rights Agreement can be amended as set forth in this Amendment by approval of the Company and affirmative vote of a majority in interest of each of the Schedule I Purchasers and FFC Purchasers;

  
 NOW, THEREFORE, in consideration of the foregoing and
the mutual agreements and covenants set forth herein and other good and valuable consideration, the parties hereto agree as follows: 
  
 1. Amendment to Registration Rights Agreement. Schedule I to the Registration Rights Agreement is hereby amended to include each of the persons set
forth in Exhibit A hereto “Joining Persons”), upon such Joining Persons’ execution and delivery of a Joinder Agreement substantially in the form attached hereto as Exhibit B. 
  
 2. Miscellaneous. 
  
 (a) This Amendment shall be governed by and construed in accordance with the
laws of the State of New York. 
  
 (b) This Amendment may be
executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
  
 (c) Headings and section reference numbers in this Amendment are for reference purposes only and shall not in any way affect the meaning or interpretation
of this Amendment. 
  
 (d) This Amendment is limited precisely as
written and shall not be deemed to be a modification, acceptance or waiver of any other term, condition or provision of the Registration Rights Agreement. 
  
 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written. 
  

			
	 CONCENTRA INC.

		
	By:	 	/s/    Richard A. Parr II
	 	 	         Richard A. Parr II
         Executive Vice President

  
 [Schedule I
Purchaser and FFC Purchaser Signature Page Follows] 
  

 2 

 Schedule I Purchasers: 
  

							
	WELSH, CARSON, ANDERSON & STOWE VIII, L.P.
		
	By:	 	WCAS VIII Associates, L.L.C.
	 	 	General Partner
			
	 	 	By:	 	/s/ Paul B. Queally
	 	 	 	 	Managing Member
	
	WELSH, CARSON, ANDERSON & STOWE VI, L.P.
		
	By:	 	WCAS VI ASSOCIATES, L.L.C.
	 	 	General Partner
			
	 	 	By:	 	/s/ Jonathan M. Rather
	 	 	 	 	Jonathan M. Rather
	 	 	 	 	Attorney -in-Fact

  
 FFC Purchasers:

  

							
	 	 	FERRER FREEMAN & COMPANY, LLC
	 	 	 on behalf of FFC PARTNERS I, L.P.
 and as its General Partner

			
	 	 	By:	 	 /s/ Carlos A. Ferrer

	 	 	 	 	 Carlos A. Ferrer

	 	 	 	 	 Manager

		
	 	 	 and
  
 on behalf of FFC EXECUTIVE PARTNERS I, L.P.
 and as its General Partner

			
	 	 	 By:
	 	 /s/ Carlos A. Ferrer

	 	 	 	 	 Carlos A. Ferrer

	 	 	 	 	 Manager

		
	 	 	 and
  
 on behalf of FFC PARTNERS II, L.P.
 and as its General Partner

			
	 	 	 By:
	 	 /s/ Carlos A. Ferrer

	 	 	 	 	 Carlos A. Ferrer

	 	 	 	 	 Manager

  

 3 

 EXHIBIT A 
  
 Joining Party 
  
 Norman C. Payson, M.D. 

 EXHIBIT B 
  
 Form of Joinder Agreement 
  
 JOINDER AGREEMENT 
  
 This Joinder Agreement (the “Joinder”) to the Amendment No. 5 to Registration Rights Agreement, dated as of August 17, 1999 (as
amended, the “Registration Rights Agreement”), among Concentra Inc. (f/k/a Concentra Managed Care, Inc.), a Delaware corporation (“Concentra”), and the several persons named in Schedules I and II thereto, is executed and
delivered by Norman C. Payson, M.D. (the “Joining Party”) as of November 28, 2005. Each capitalized term used but not otherwise defined herein shall have the meaning set forth in the Registration Rights Agreement. 
  
 1. Agreement to be Bound. The Joining Party hereby agrees to be bound
by all of the terms of the Registration Rights Agreement, attached to this Joinder as Exhibit A (as the same may be hereafter amended, restated, or otherwise modified from time to time). The Joining Party shall hereafter be deemed to be a
“Schedule I Purchaser” and a “Purchaser” for all purposes under the Registration Rights Agreement. 
  
 2. Concentra Representations and Warranties. Concentra’s representations and warranties contained in the Registration Rights Agreement are
true and correct in all material respects as of the date hereof. 
  
 3. Notices. For purposes of notices and other communications to be delivered to the Joining Party, the addresses and facsimile numbers set forth below shall be deemed an amendment to Schedule I of the Registration Rights Agreement
with respect to the Joining Party. 
  
 4. Governing Law.
This Joinder Agreement shall be governed by and construed in accordance with the laws of the State of New York. 
  

									
	AGREED AND ACCEPTED	 	 	 	 
	 	 	 	 	 Signature of Joining Party

	CONCENTRA INC.	 	 	 	 
	By:	 	 	 	 	 	 	 	 Norman C. Payson, M.D.
 NCP, Inc.

	 	 	 Richard A. Parr II
 Executive Vice President
	 	 	 	 	 	 8 Centre Street, Suite 3
 Concord, New Hampshire
03301

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}]]